| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Organon & Co (NYSE: OGN)
OGN Technical Analysis
5
| As on 9th Jun 2023 OGN STOCK Price closed @ 19.83 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 31.64 & Strong Sell for SHORT-TERM with Stoploss of 33.13 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OGNSTOCK Price
| Open | 19.94 | Change | Price | % |
| High | 20.21 | 1 Day | -0.18 | -0.90 |
| Low | 19.77 | 1 Week | 0.29 | 1.48 |
| Close | 19.83 | 1 Month | -3.76 | -15.94 |
| Volume | 2290032 | 1 Year | -10.36 | -34.32 |
| 52 Week High 39.36 | 52 Week Low 19.27 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| OGN Daily Charts |
OGN Intraday Charts |
Whats New @ Bazaartrend |
OGN Free Analysis |
|
|
OGN Important Levels Intraday
| RESISTANCE | 20.68 |
| RESISTANCE | 20.41 |
| RESISTANCE | 20.24 |
| RESISTANCE | 20.07 |
| SUPPORT | 19.59 |
| SUPPORT | 19.42 |
| SUPPORT | 19.25 |
| SUPPORT | 18.98 |
OGN Forecast May 2024
| 4th UP Forecast | 32.16 |
| 3rd UP Forecast | 28.21 |
| 2nd UP Forecast | 25.76 |
| 1st UP Forecast | 23.32 |
| 1st DOWN Forecast | 16.34 |
| 2nd DOWN Forecast | 13.9 |
| 3rd DOWN Forecast | 11.45 |
| 4th DOWN Forecast | 7.5 |
OGN Weekly Forecast
| 4th UP Forecast | 22.28 |
| 3rd UP Forecast | 21.49 |
| 2nd UP Forecast | 21.01 |
| 1st UP Forecast | 20.52 |
| 1st DOWN Forecast | 19.14 |
| 2nd DOWN Forecast | 18.65 |
| 3rd DOWN Forecast | 18.17 |
| 4th DOWN Forecast | 17.38 |
OGN Forecast2024
| 4th UP Forecast | 59.55 |
| 3rd UP Forecast | 46.81 |
| 2nd UP Forecast | 38.94 |
| 1st UP Forecast | 31.06 |
| 1st DOWN Forecast | 8.6 |
| 2nd DOWN Forecast | 0.72 |
| 3rd DOWN Forecast | -7.15 |
| 4th DOWN Forecast | -19.89 |
Organon & Co ( NYSE USA Symbol : OGN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OGN Business Profile
Organon & Co., a science-based pharmaceutical company, develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio in the United States, Canada, Australia, and Ukraine. It also has a portfolio of established brands in cardiovascular, respiratory, dermatology, and non-opioid pain management. The company sells its products primarily to drug wholesalers and retailers, hospitals, government agencies, and managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey. Organon & Co. operates independently of Merck & Co., Inc. as of June 2, 2021. Address: 30 Hudson Street, Jersey City, NJ, United States, 07302
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service